Alex Goldberg

NASDAQ Active Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE) and BlackBerry Limited (NASDAQ:BBRY) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/13/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Galena Biopharma, Inc. (NASDAQ:GALE) and BlackBerry Limited (NASDAQ:BBRY).

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care is currently up (+12.76%) on 16,175,623 shares traded after Galena price target has been raised to $11 from $7 at Roth Capital. Galena Biopharma, Inc. (NASDAQ:GALE) is currently up (+360.61%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Galena Biopharma, Inc. (NASDAQ:GALE)

BlackBerry Limited (NASDAQ:BBRY) a company that engages in the design, manufacture, and marketing of wireless solutions worldwide is currently down (-4.05%) on 19,037,361 shares traded after BlackBerry announced that Eric Johnson will join the Company as President, Global Sales reporting to BlackBerry's Executive Chair and CEO, John Chen. BlackBerry Limited (NASDAQ:BBRY) is currently down (-55.13%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about BlackBerry Limited (NASDAQ:BBRY)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com